Alligator Bioscience AB (publ) (STO:ATORX)
Sweden · Delayed Price · Currency is SEK 0.0366
-0.0002 (-0.54%)
Aug 13, 2026, 5:29 PM CET
Alligator Bioscience AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.34 | 6.42 | 59.71 | 61.9 | 37.14 | 15.13 | |
Revenue Growth | -97.67% | -89.25% | -3.54% | 66.69% | 145.50% | 126.88% |
Gross Profit | 1.34 | 6.42 | 59.71 | 61.9 | 37.14 | 15.13 |
Selling, General & Admin | 91.71 | 120.79 | 237.64 | 298.17 | 216.56 | 144.8 |
Depreciation & Amortization Expenses | -11.1 | -10.25 | 48.73 | 10.49 | 11.77 | 11.14 |
Other Operating Expenses | 0.64 | 1.71 | 2.49 | 2.23 | 1.6 | 0.75 |
Total Operating Expenses | 81.25 | 112.25 | 288.85 | 310.89 | 229.93 | 156.69 |
Operating Income | -79.91 | -105.83 | -229.14 | -248.98 | -192.79 | -141.57 |
Total Non-Operating Income (Expense) | 38.35 | 103.12 | 15.59 | 0.4 | -0.61 | -0.17 |
Pretax Income | -41.56 | -51.35 | -233.89 | -248.59 | -193.4 | -141.74 |
Net Income | -41.56 | -51.35 | -233.89 | -248.59 | -193.4 | -141.74 |
Net Income to Common | -41.56 | -51.35 | -233.89 | -248.59 | -193.4 | -141.74 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 161 | 28 | 1 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 161 | 28 | 1 | 0 | 0 | 0 |
Shares Change | 6492.90% | 3648.83% | 63.72% | 103.32% | 146.00% | 25.61% |
EPS (Basic) | -1.08 | -1.87 | -318.53 | -0.55 | -880.00 | -1580.00 |
EPS (Diluted) | -1.08 | -1.87 | -318.53 | -0.55 | -880.00 | -1580.00 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -113.15 | -157.45 | -221.78 | -191.74 | -173.05 | -127.08 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.70 | -5.72 | -302.04 | -427.53 | -784.49 | -1417.17 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -5963.66% | -1648.38% | -383.74% | -402.22% | -519.16% | -935.90% |
Profit Margin | -3101.79% | -799.84% | -391.70% | -401.58% | -520.81% | -937.04% |
FCF Margin | -8443.96% | -2452.43% | -371.41% | -309.75% | -465.99% | -840.13% |
EBITDA | -91.01 | -116.07 | -180.41 | -238.49 | -181.02 | -130.42 |
EBITDA Margin | -6791.57% | -1807.98% | -302.14% | -385.28% | -487.47% | -862.23% |
EBIT | -79.91 | -105.83 | -229.14 | -248.98 | -192.79 | -141.57 |
EBIT Margin | -5963.66% | -1648.38% | -383.74% | -402.22% | -519.16% | -935.90% |